Connect with us

CBD News

Minnesota Could See $300 Million in Revenue Due to Cannabis Legalization



Minnesota Could See $300 Million in Revenue Due to Cannabis Legalization

According to a recent report by MinnPost, the revenues from recreational marijuana in Minnesota could reach $300 million in taxes.

The report adds that $1.2 billion in sales within five years of legalization could occur, in addition to 20,00 direct and indirect jobs. The tax revenue from that $1.2 billion would be $300 million.

These are estimates presented by Sal Barnes, the director of the Marijuana Policy Group. The policy group consults with the government and businesses about marijuana policies and planning.

The report also indicates that 7.9 percent of Minnesotans use cannabis at least once per month. This is under the national average of 9.5 percent. It is also under the 20 percent post-legalization rate.

David Renfrew is just now beginning his journey at TOC but has found himself on the forefront of the Canadian cannabis culture and marijuana movement. Among being a vocal CBD advocate, Dave is also a politically active father, author, small business owner and fierce reader of fiction and non-fiction. While early, the strong research skills and truly gifted writing talent make David one of our top editors.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.